Prelude Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$400K Sell
5,802
-11,412
-66% -$788K 0.04% 502
2025
Q1
$1.2M Buy
+17,214
New +$1.2M 0.09% 214
2024
Q4
Sell
-5,390
Closed -$642K 1315
2024
Q3
$642K Buy
5,390
+3,288
+156% +$392K 0.04% 467
2024
Q2
$300K Buy
+2,102
New +$300K 0.02% 714
2024
Q1
Sell
-11,247
Closed -$1.16M 1352
2023
Q4
$1.16M Buy
11,247
+5,247
+87% +$543K 0.08% 225
2023
Q3
$546K Sell
6,000
-8,690
-59% -$790K 0.04% 360
2023
Q2
$1.19M Sell
14,690
-5,510
-27% -$446K 0.08% 244
2023
Q1
$1.61M Buy
20,200
+1,054
+6% +$83.9K 0.1% 220
2022
Q4
$1.3M Sell
19,146
-5,088
-21% -$344K 0.07% 280
2022
Q3
$1.21M Buy
+24,234
New +$1.21M 0.04% 359
2022
Q1
Sell
-15,808
Closed -$885K 1782
2021
Q4
$885K Buy
15,808
+1,268
+9% +$71K 0.02% 512
2021
Q3
$698K Buy
14,540
+3,058
+27% +$147K 0.02% 530
2021
Q2
$481K Buy
11,482
+68
+0.6% +$2.85K 0.01% 778
2021
Q1
$385K Buy
11,414
+2,216
+24% +$74.7K 0.01% 690
2020
Q4
$321K Buy
+9,198
New +$321K 0.01% 493
2019
Q4
Sell
-17,736
Closed -$458K 1658
2019
Q3
$458K Buy
+17,736
New +$458K 0.02% 289
2019
Q2
Sell
-22,660
Closed -$593K 1580
2019
Q1
$593K Buy
+22,660
New +$593K 0.03% 253
2016
Q4
Sell
-3,400
Closed -$71K 1654
2016
Q3
$71K Buy
+3,400
New +$71K 0.01% 875
2015
Q2
Sell
-1,800
Closed -$48K 1842
2015
Q1
$48K Hold
1,800
0.01% 1246
2014
Q4
$38K Sell
1,800
-24,300
-93% -$513K 0.01% 1342
2014
Q3
$624K Hold
26,100
0.09% 267
2014
Q2
$601K Buy
+26,100
New +$601K 0.08% 276
2014
Q1
Sell
-32,300
Closed -$591K 1834
2013
Q4
$591K Hold
32,300
0.1% 264
2013
Q3
$548K Sell
32,300
-24,440
-43% -$415K 0.09% 234
2013
Q2
$884K Buy
+56,740
New +$884K 0.19% 104